News
Breakfast with Champions to Benefit Prostate Cancer Research Feb. 22
The University of California, San Diego will host its first-ever fundraiser for prostate cancer research, “Breakfast with Champions,” on Friday, Feb. 22 at the La Jolla Country Club. The event will feature Pro Football Hall of Famers and prostate cancer survivors Mike Haynes and Deacon Jones who will discuss their experiences as champions, both on and off the field. The public is invited; all proceeds from the event will benefit prostate cancer research at the UC San Diego School of Medicine.
Excess Protein Linked to Development of Parkinson’s Disease
Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells’ center, with the potential consequence of progressive degeneration and eventual cell death.
February 07, 2013 • General, Health, Science and Engineering
UC San Diego Funded by NIMH to Study Successful Aging in Adults with HIV
The National Institute of Mental Health has awarded a $3.4 million grant to a team of researchers at the University of California, San Diego School of Medicine to study successful aging in HIV-infected adults. HIV is a serious, chronic, medical disease that affects the lives of more than one million Americans.
February 04, 2013 • General, Health, Science and Engineering
Alternative Hip Replacement Technique Results in Faster Recovery
University of California, San Diego Health System is one of only a few hospitals in the nation to offer computer-assisted navigation technology with the direct anterior hip replacement technique, potentially resulting in less pain, faster recovery and fewer dislocations for patients with osteoarthritis and other forms of degenerative joint disease.
February 04, 2013 • General, Health, Science and Engineering
More Links Found Between Schizophrenia and Cardiovascular Disease
A new study, to be published in the Feb. 7, 2013 issue of the American Journal of Human Genetics, expands and deepens the biological and genetic links between cardiovascular disease and schizophrenia. Cardiovascular disease (CVD) is the leading cause of premature death among schizophrenia patients, who die from heart and blood vessel disorders at a rate double that of persons without the mental disorder.
Low Vitamin D Levels Linked to High Risk of Premenopausal Breast Cancer
A prospective study led by researchers from the University of California, San Diego School of Medicine has found that low serum vitamin D levels in the months preceding diagnosis may predict a high risk of premenopausal breast cancer.
Flu Season Survival Guide
It’s that time of year again: flu season. The epidemic this year is widespread, afflicting millions in every state across the country. This year’s flu strain has been reported as particularly virulent, but there are essential steps that the UC San Diego community is encouraged to take to prevent contracting and spreading the flu.
Blocking Digestive Enzymes May Reverse Shock, Stop Multiorgan Failure
New research from the University of California, San Diego published in the Jan. 23 issue of Science Translational Medicine moves researchers closer to understanding and developing treatments for shock, sepsis and multiorgan failure. Collectively, these maladies represent a major unmet medical need: they are the number one cause of mortality in intensive care units in the United States, with hundreds of thousands of deaths annually. There is currently no treatment for these conditions in spite of many clinical trials.
Annual Heart of San Diego Gala Honors Audrey Geisel Feb. 9
The University of California, San Diego’s 16th annual Heart of San Diego Gala will honor local philanthropist and community leader Audrey Geisel Feb. 9 at the Grand Hyatt Aviara Resort. The formal fete will include dinner, dancing and a silent auction. Former San Diego Charger Rolf Benirschke will serve as the evening’s emcee. All proceeds from the event will benefit the UC San Diego Sulpizio Cardiovascular Center.
Drug Targets Hard-to-Reach Leukemia Stem Cells Responsible for Relapses
Researchers at the University of California, San Diego School of Medicine have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms are sensitive – and thus vulnerable – to a novel cancer stem cell-targeting drug currently under development.
Top Stories
Excess Protein Linked to Development of Parkinson’s Disease
Working Alone Won’t Get You Good Grades
Shu Chien Named San Diego Festival of Science & Engineering Chief Engineer
UC San Diego Named to Princeton Review’s List of Best Value Colleges for 2013
UC San Diego Ranks No. 13 Nationally on the Peace Corps Top Colleges List
